Literature DB >> 4027160

Detection of the c-myc oncogene product in testicular cancer.

K Sikora, G Evan, J Stewart, J V Watson.   

Abstract

A set of monoclonal antibodies was constructed by immunising mice with peptide fragments of the c-myc oncogene product. One such antibody, Myc 1-6E10 was shown to bind to a 62,000 dalton protein identifiable with the c-myc product (p62c-myc). The antigen recognised was not destroyed by paraffin wax embedding. Myc 1-6E10 was used to characterise the distribution of p62c-myc in archival testicular tumour material. Normal testes expressed only small amounts of p62c-myc. Seminomas showed increased nuclear and cytoplasmic staining. Undifferentiated teratoma showed little activity, whereas p62c-myc was abundant in the nuclei of differentiating epithelial structures, yolk sacs and embryoid bodies. Only small amounts of p62c-myc were seen in the tumours of 5 patients who subsequently died from their disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027160      PMCID: PMC1977100          DOI: 10.1038/bjc.1985.174

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Oncogenes.

Authors:  P Hamlyn; K Sikora
Journal:  Lancet       Date:  1983-08-06       Impact factor: 79.321

Review 3.  Cancer genes come of age.

Authors:  J M Bishop
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

4.  Expression of a cellular oncogene during liver regeneration.

Authors:  M Goyette; C J Petropoulos; P R Shank; N Fausto
Journal:  Science       Date:  1983-02-04       Impact factor: 47.728

5.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.

Authors:  R Müller; D J Slamon; J M Tremblay; M J Cline; I M Verma
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

6.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

7.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

8.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

9.  Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia.

Authors:  D M McCarthy; F V Rassool; J M Goldman; S V Graham; G D Birnie
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

Review 10.  The emerging genetics of human cancer.

Authors:  T G Krontiris
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

View more
  33 in total

1.  c-myc coded oncoprotein for immunotargeting. Oropharyngeal and other tumors at S.N. Medical College, Agra, India.

Authors:  V L Lahiri; D K Hazra; B R Elhence; B Mukerji; G Kalra; V Mehrotra; K Singh
Journal:  Cell Biophys       Date:  1992 Aug-Dec

2.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  Testis-specific expression of the human MYCL2 gene.

Authors:  N G Robertson; R J Pomponio; G L Mutter; C C Morton
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

4.  The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function.

Authors:  Q Sheng; D Denis; M Ratnofsky; T M Roberts; J A DeCaprio; B Schaffhausen
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  c-myc oncoprotein levels in bladder cancer.

Authors:  J R Masters; S G Vesey; C F Munn; G I Evan; J V Watson
Journal:  Urol Res       Date:  1988

6.  c-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution.

Authors:  S L Loke; L M Neckers; G Schwab; E S Jaffe
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

Review 7.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

8.  DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.

Authors:  Jinfei Xu; Joseph R Testa
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

9.  Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

Authors:  M Curling; S Stenning; C N Hudson; J V Watson
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

10.  C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy.

Authors:  S V Polacarz; N A Hey; T J Stephenson; A S Hill
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.